http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Sunovion to Present Data on Latuda® (lurasidone HCl) at the 169th Annual Meeting of the American Psychiatric Association
-
Sunovion Presents New Health Outcomes Data Supporting Brovana® (arformoterol tartrate) Inhalation Solution in People with Moderate-to-Severe COPD at the 2016 American Thoracic Society (ATS) Internati
-
Sunovion Pharmaceuticals Inc. Announces Positive Results from Two Phase 3 Clinical Studies Evaluating SUN-101/eFlow® (glycopyrrolate) in People with Moderate-to-Very Severe Chronic Obstructive Pulmon
-
Sunovion Announces Results of Health Outcomes Analyses Supporting the Use of Aptiom® (eslicarbazepine acetate) in People with Partial-Onset Seizures at the 68th American Academy of Neurology (AAN) An
-
Sunovion to Present Data Analyses Supporting Use of Aptiom® (eslicarbazepine acetate) at the 68th American Academy of Neurology (AAN) Annual Meeting
-
New Health Outcomes Data Reinforce Role of Device Selection and Peak Inspiratory Flow Rate in Treatment of COPD Patients
-
Sunovion Announces Results from a Study Evaluating the Abuse Potential of Investigational Drug Dasotraline
-
Sunovion Announces Results of Health Outcomes Analyses Exploring the Effectiveness of Aptiom® (eslicarbazepine acetate) in People with Partial-Onset Seizures
-
Sunovion to Present New Research and Data Analyses Supporting Use of Aptiom® (eslicarbazepine acetate) at the American Epilepsy Society (AES) 69th Annual Meeting
-
Sunovion and the COPD Foundation Launch Reel COPD to Support Family Caregivers
-
Sunovion to Present Health Outcomes Data Supporting Brovana® (arformoterol tartrate) Inhalation Solution in Patients with COPD at the 2015 American College of Chest Physicians Annual Meeting
-
Sunovion Celebrates Five-Year Anniversary Milestone
